Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

July 01, 1999; 53 (1) Editorials

CACNA1A mutations

Hemiplegic migraine, episodic ataxia type 2, and the others

Elisabeth Tournier-Lasserve
First published July 1, 1999, DOI: https://doi.org/10.1212/WNL.53.1.3
Elisabeth Tournier-Lasserve
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
CACNA1A mutations
Hemiplegic migraine, episodic ataxia type 2, and the others
Elisabeth Tournier-Lasserve
Neurology Jul 1999, 53 (1) 3; DOI: 10.1212/WNL.53.1.3

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
853

Share

  • Article
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

In 1996, Ophoff et al.1 showed that familial hemiplegic migraine (FHM) and episodic ataxia type 2 (EA2) are both caused by mutations within CACNA1A, a gene encoding for the α1A subunit of a neuronal P/Q type calcium channel. Molecular analysis of five unrelated FHM and two EA2 families as well as one EA2 sporadic case suggested that these two clinically distinct conditions may be due to distinct types of mutations within CACNA1A: missense mutations in FHM and truncating mutations in EA2.1,2 More recently, a recurrent missense mutation, T666M, was identified in most families affected by FHM with progressive cerebellar ataxia.3 In this issue, Battistini et al.4 and Carrera et al.5 identified in two additional FHM families missense mutations located within important functional regions of CACNA1A. Also in this issue, Jen et al.6 identify a truncating mutation within an EA2 family. Interestingly, two members of the pedigree experienced hemiparesis during some of their ataxic spells. Altogether these data confirmed the distinct nature of the mutations causing these two conditions. However, the detailed clinical analyses of the families reported in this issue of Neurology bring additional clinically important information.

FHM and EA2: Two clinically distinct conditions.

FHM is an autosomal dominant form of migraine with aura in which the aura is characterized by motor weakness of variable intensity.7 Symptoms include both typical migraine and severe episodes with prolonged aura (up to several days or weeks), impaired consciousness ranging from confusion to profound coma, …

View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • FHM and EA2: Two clinically distinct conditions.
    • FHM and EA2 are caused by distinct types of mutations within CACNA1A.
    • Genotype-phenotype correlations in CACNA1A-related conditions: A broader than expected clinical spectrum.
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

Direct Health Care Costs Associated With Multiple Sclerosis: A Population-Based Cohort Study in British Columbia, Canada, 2001-2020

Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft

► Watch

Related Articles

  • Genetic heterogeneity in Italian families with familial hemiplegic migraine
  • A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia
  • A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine
    G. M. Terwindt, R. A. Ophoff, J. Haan et al.
    Neurology, April 01, 1998
  • Articles
    A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia
    S. Battistini, S. Stenirri, M. Piatti et al.
    Neurology, July 01, 1999
  • Articles
    High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2
    C. Denier, A. Ducros, K. Vahedi et al.
    Neurology, June 01, 1999
  • Views & Reviews
    Clinical spectrum of episodic ataxia type 2
    J. Jen, G. W. Kim, R. W. Baloh et al.
    Neurology, January 12, 2004
Neurology: 101 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise